EyePoint Pharmaceuticals, Inc. — Form D

EyePoint Pharmaceuticals, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-06. The offering totals $15.7M, of which $15.7M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Goran AndoDirectorWATERTOWN, MA
Wendy O DiCiccoDirectorWatertown, MA
Ronald W EastmanDirectorWatertown, MA
Douglas W GodshallDirectorWatertown, MA
David R Guyer, M.D.DirectorWatertown, MA
John R Landis, Ph.D., M.S.DirectorWatertown, MA
Ye R LiuDirectorWatertown, MA
Nancy LurkerDirectorWATERTOWN, MA
George O ElstonExecutive OfficerWatertown, MA
Scott JonesExecutive OfficerAustin, TX
Nancy LurkerExecutive OfficerWATERTOWN, MA
Dario Paggiarino, M.D.Executive OfficerWATERTOWN, MA
Michael RogersDirectorEDEN PRAIRIE, MN
James BarryDirectorAMERICAN CANYON, CA
Kristine PetersonDirectorAbingdon, Oxfordshire, X0
David MazzoDirectorGermantown, MD
Douglas GodshallDirectorSanta Clara, CA
Dario S PaggiarinoExecutive OfficerWATERTOWN, MA
Leonard S RossExecutive OfficerWATERTOWN, MA
Jay DukerDirectorWATERTOWN, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2018-04-12D$35.0M$9.5M
2018-04-12D$600K$450K

More